MANAGEMENT OF PATIENT WITH DEMENTIA SSA PERSPECTIVE

Similar documents
If you have dementia, you may have some or all of the following symptoms.

Michael A. Lobatz MD The Neurology Center Scripps Rehabilitation Center

Alzheimer s Disease. Pathophysiology: Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior,

Forgetfulness: Knowing When to Ask for Help

Diagnosis and Treatment of Alzhiemer s Disease

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review

To help you prepare for your doctor's visit, the Alzheimer Society has developed the following list:

Dementia Basics. Welcome! What to expect and how to handle a dementia diagnosis. In partnership with Scripps Health.

Introduction to Dementia: Diagnosis & Evaluation. Created in March 2005 Duration: about 15 minutes

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

Dr Georgina Train Consultant Psychiatrist EMDASS service and Continuing Care.

Dr. Adeniyi Mofoluwake and Stacy Kramer

BEHAVIORAL PROBLEMS IN DEMENTIA

Evaluations. Alzheimer s Disease A Public Health Response. Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors:

Cognitive disorders. Dr S. Mashaphu Department of Psychiatry

Recognition and Management of Behavioral Disturbances in Dementia

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

Alzheimer s disease. The facts in brief

4/11/2017. The impact of Alzheimer s disease. Typical changes. The impact of Alzheimer s disease. Problematic changes. Problematic changes

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

homeinstead.com Each Home Instead Senior Care franchise office is independently owned and operated Home Instead, Inc.

Understanding. Alzheimer s Disease. Lora, diagnosed in 2004, with her daughter, Jill.

Community Pharmacy Dementia Audit

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Seniors Helping Seniors September 7 & 12, 2016 Amy Abrams, MSW/MPH Education & Outreach Manager Alzheimer s San Diego

Module: Dementia. Overview. Learning objectives. Key messages DEM

Understanding Dementia

Diagnosis and assessment

DEMENTIA Dementia is NOT a normal part of aging Symptoms of dementia can be caused by different diseases Some symptoms of dementia may include:

Alzheimer Disease and Related Dementias

Common Forms of Dementia Handout Package

Alzheimer Disease and Related Dementias. Alzheimer Society of Manitoba Dr. David Strang

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Understanding Dementia

Cognitive and Behavioral Changes in ALS: A Guide for People with ALS and their Families

Appendix K: Evidence review flow charts

Resources: Types of dementia

Medications for Alzheimer s disease: are they right for you?

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

Evaluating an Apparent Unprovoked First Seizure in Adults

Dr. W. Dalziel Professor, Geriatric Medicine Ottawa Hospital. November /20/ Safety: Falls/Cooking/Unsafe Behaviour. 2.

Memory & Aging Clinic Questionnaire

These conditions can have similar and overlapping symptoms, and many of them can only be diagnosed with certainty by autopsy of the brain.

Behavioral and Psychological Symptoms of dementia (BPSD)

WHAT S NEW IN THE FIGHT AGAINST DEMENTIA

Memory Loss, Dementia and Alzheimer's Disease: The Basics

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

Dementia Facts and Resources Dementia Warning Signs Getting a Diagnosis Dementia Communication Tips Dementia Risk Reduction.

Research & Policy Brief

For the Lifespan: The Caregiver Guide Module 2 Dementia and Memory Loss

In-Service Education. workbook 3. by Hartman Publishing, Inc. second edition

Dementia and Delirium

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Raj C. Shah, MD Associate Professor in Family Medicine Rush Alzheimer s Disease Center Rush University Medical Center

OUR BRAINS!!!!! Stroke Facts READY SET.

How to Spot. How to Spot. the Early Signs of Alzheimer s

The Basics of Alzheimer s Disease

This information explains the advice about supporting people with dementia and their carers that is set out in NICE SCIE clinical guideline 42.

What is dementia? Symptoms of dementia. Memory problems

Alzheimer s disease and related disorders. Patient risks

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

Introduction to Dementia: Complications

A BRIEF LOOK AT DEMENTIA

Dementia is not normal aging!

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

Alzheimer s Disease. Fact Sheet. Fact Sheet. Fact Sheet. What Causes AD?

Multiple Sclerosis. What is multiple sclerosis? What is the cause? What are the symptoms?

Alzheimer s Disease Update: From Treatment to Prevention

Dementia. Information for service users and carers. RDaSH leading the way with care

10/17/2017. Causes of Dementia Alzheimer's Disease Vascular Dementia Diffuse Lewy Body Disease Alcoholic Dementia Fronto-Temporal Dementia Others

Alzheimer s Disease - Dementia

Department of Geriatric Medicine

What is Alzheimer s disease

Alzheimer s disease. What is Alzheimer s disease?

Alzheimer's Disease. Dementia

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Decline in Mental Capacity

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

ASK IF NAMZARIC MAY BE RIGHT FOR THEM.

Rational Medication Use in Dementia

Geriatric Alterations Associated with Neurological Conditions

Pharmacological Treatment of Dementia

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs

Assessing and Managing the Patient with Cognitive Decline

PROJECTION: Worlds dementia population is expected to triple by 2050

Dementia is an overall term for a set of symptoms that is caused by disorders affecting the brain.

What is Alzheimer s disease?

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

Appendix 2 (continued): Recommendations for the management of mild to moderate dementia, dementia with a cerebrovascular component, and for addressing

Psychotropic Strategies Handout Package

Dementia Chronic Brain Failure The forgotten cardiovascular disease Clare Hawley 2015

ALZHEIMER S DISEASE, DEMENTIA & DEPRESSION

Alzheimer s disease dementia: a neuropsychological approach

Mental Health Rotation Educational Goals & Objectives

Functional Assessment Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico

Significance A Busy Clinician's Guide to Seniors with Memory Loss

Dementia Diagnosis Guidelines Primary Care

Transcription:

MANAGEMENT OF PATIENT WITH DEMENTIA SSA PERSPECTIVE Njideka U. Okubadejo, MBChB, FMCP Associate Professor & Consultant Neurologist College of Medicine, University of Lagos, & Lagos University Teaching Hospital Lagos, Nigeria

OUTLINE Background Approach to management History taking Physical education Cognitive testing Laboratory investigations Neuroimaging Treatment: Pharmacological/Non-pharmacological Issues in management in SSA

BACKGROUND Chronic, typically progressive neurologic disorder. Adversely affects higher cortical functions including memory, thinking and orientation. Most common cause is Alzheimer s disease. Significantly impairs quality of life. Associated with disability, mortality, significant psychosocial and economic consequences for individual affected, their families, communities and nations.

Case history Mrs. OL, a 75 year old retired primary school teacher is brought to the clinic, accompanied by her daughter, who complains that her previously meticulous mother is increasingly forgetful, missing appointments, misplacing her handbag and money, and less wellkempt than before. She thinks this has been going on for about a year, and recently has difficulty recalling the date and month. She seems more withdrawn, and avoids coming out of her room when there are guests in the house. She also started wandering about aimlessly and formed a habit of keeping her unwashed underwear under her pillow. She often insists that she has had a bath, and resists being assisted to bathe in the mornings. There have been a few episodes of bedwetting at night. She prefers to wear the same clothes repeatedly despite a drawer full of new clothe bought by her daughter. About a week ago, her daughter relocated her to her home, and since then she appears more confused, often losing her way within the house. Mrs. OL is of the opinion that nothing is wrong and her daughter has brought her to you for a normal checkup.

Questions o Do you think the daughter is overly concerned and there is nothing wrong as the patient asserts? o What will your approach be to establishing a diagnosis? o Who will you focus management on: mother or daughter?

Approach to management Thorough history Physical examination Cognitive testing Laboratory investigations Neuroimaging Patient and caregiver education Nonpharmacologic treatment Pharmacologic treatment Follow-up visits

History taking Establish reason(s) for consultation Allow patient account and caregiver account Explore aspects of cognitive functioning (memory, language use, etc) and effect on activities of daily living Ask about behavioural changes withdrawal, aggressiveness, sexual disinhibition, wandering, etc. Enquire concerning mode of onset, duration, progression of symptoms, other neurologic symptoms (including depression), general medical history. Specifically ask about: diabetes, hypertension, cigarette smoking, alcohol use, nutrition, family history.

Physical examination Be gentle and explain what you want to do to the patient General physical examination: look out for anemia, clues to malnutrition, general hygiene Neurologic examination: examine for focal lesions (especially cranial nerves and muscle power), asymmetry, deep tendon reflexes, primitive reflexes Examine the cardiovascular system: pulse, blood pressure, praecordium

Cognitive testing Perform a bedside cognitive test MMSE most widely used Some local translations available Be aware that educational level may affect responses. May use alternative tests that are less affected by education/literacy. Learn to interpret the findings in conjunction with history and other features (not in isolation)

Cognitive testing ii Severity of cognitive impairment using MMSE Normal cognitive function: MMSE 27-30 Mild cognitive impairment: MMSE 21 26 Moderate cognitive impairment : MMSE 10 20 Severe cognitive impairment : MMSE <10 Reference: NICE, UK

Laboratory investigations Baseline (to exclude reversible causes of dementia) Full blood count (Hb, WBC, differentials, platelets) Serum electrolytes, BUN, creatinine Blood glucose Lipid profile Serology (HIV) may be done Serum B12 levels (urine MMA) if available Liver function tests Thyroid function tests May be indicated: EEG, Lumbar puncture

Neuroimaging To exclude structural cause of dementia To explore for other forms of dementia: vascular, normal pressure hydrocephalus Brain CT scan Brain MRI scan

AD MRI brain scan Normal Alzheimer's disease (advanced) Coronal MRIs. In AD, widened sulci, enlarged ventricles and gaping temporal horns, reflecting cortical and hippocampal atrophy.

Treatment of reversible dementia Treat any reversible cause found (e.g. hypothyroidism) May be a co-morbidity rather than actual cause of cognitive decline Reassess cognitive function after a reasonable period following treatment of potentially reversible cause Reassessment after 3 6 months reasonable If still impaired, consider Alzheimer's or other irreversible dementia

TREATMENT OF ALZHEIMER S DEMENTIA

Goals of treatment Maintain / improve quality of life Improve / maximize functioning Slow decline in cognition (if feasible) Treat/control/modify co-morbid mood, behavioural and medical conditions Ease caregiver burden

Patient and caregiver education Key to successful management May require separate encounters. Obtain consent from patient where feasible Identify responsible family member(s) to communicate diagnosis and care plan Empathetically convey prognosis/expected progression Emphasize importance of general care, safety, assistance, social support Discuss treatment options /expected responses (including cost implications)

APPROACH TO TREATMENT Multidisciplinary approach!!! Neurologist/Geriatrician/Psychiatrist/Physician with special interest in dementia/geriatrics/neurology Nurse/nurse specialists Neuropsychologist/clinical psychologist Physical therapists Occupational therapists Social worker Others.

Pharmacologic treatment Applicable to: treatment of cognitive symptoms treatment of co-morbid mood / behavioural problems treatment of any co-morbid disease (e.g. hypertension or diabetes)

Pharmacologic Tx: cognitive symptoms Based on cholinergic hypothesis of memory impairment: cognitive and behavioural changes in AD are due to cholinergic deficits Medication may slow decline in functioning; does not restore lost function. May not work in some. NOT A CURE FOR DEMENTIA! Cholinesterase inhibitors: Useful when impairments affect functioning Indicated for mild to moderate AD. S/E: nausea, diarrhea, dizziness Donepezil 5-10 mg/day Galantamine 4 8 mg BD (16-24 mg/d) Rivastigmine 1.5 3 mg BD (6-12 mg/d) Antiglutamate: Indicated for severe dementia. S/E: dizziness, worsen aggression, confusion Memantine: start dose: 5 mg/d, increasing gradually to 10 mg BD

Cholinesterase inhibitors should be considered in mild to moderate AD, although studies suggest a small average degree of benefit Vitamin E (1000 IU po BID) should be considered in an attempt to slow progression of AD Insufficient evidence to support use of other antioxidants, antiinflammatories, or other putative disease-modifying agents to treat AD Neurology 2001;56:1154-1166

Pharmacologic Tx: behavioural symptoms Antipsychotic medication used when environmental manipulation fails to control agitation, combativeness, or psychosis Atypical antipsychotics (e.g. risperidone) preferred to traditional agents (e.g. haloperidol) Antidepressant medication to treat depression in patients with dementia SSRI s preferred. Selected MAO-B inhibitors and tricyclic antidepressants may be used.

Non-pharmacologic treatment Regular exercise: within reason; tailored; walking; dance Regular routine: limit disruptions and changes Sleep: regular hours; daytime naps may cause insomnia Meals: regular, avoid heavy meals at night Dressing, grooming and bathing: supervise, assist, guide Toileting: prompted voiding; post-prandial voiding; adult diapers Music (esp during meals, bathing), religious activities Photo albums, familiar company, happy memories Regular brain stimulation: Ludo, cards, Sudoku, Scrabble Home/environmental modification: safety, familiarity

Caregivers / Family members Patience with repetitive behaviours Behaviours are not intentional and may not be amenable to counseling/advice/scolding Speak slowly; simple ideas; simple instructions Avoid reacting to emotional outbursts and suspicion Engage by distraction, change of scene, walks Ask for help/support take a break; get help/support Psychosocial interventions: (e.g. education, support, respite care) improve caregiver QoL and emotional well-being.

Family involvement Plan for the future Plan early while patient can still contribute Address: living conditions/arrangements finances healthcare decision making? Identification of responsible next of kin

MANAGEMENT ISSUES IN SSA Delayed diagnosis, no diagnosis and misdiagnosis Access to trained professional care Patient education Caregiver education Caregiver burden: social support Access to pharmacologic therapy: out-of-pocket cost Support services: daycare, nursing homes, rehabilitation services Cultural barriers to care Economic barriers to care